FTFrances Tse

Frances Tse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Frances Tse has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • Paul Moayyedi

    Department of Medicine, Division of Gastroenterology and Farncombe Family Digestive Health Research Institute McMaster University Hamilton Ontario Canada

    13 shared publications
  • Yuhong Yuan

    Division of Gastroenterology, Department of Medicine, Western University , London, ON N6A 5C1

    13 shared publications
  • Grigorios I Leontiadis

    Department of Medicine, Division of Gastroenterology; McMaster University; Hamilton Canada

    8 shared publications
  • Grigorios I. Leontiadis

    Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada

    8 shared publications
  • Paul Moayyedi

    Department of Medicine, Division of Gastroenterology; McMaster University; Hamilton Canada

    7 shared publications
  • David Armstrong

    Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada

    5 shared publications

Latest Publications

  • Open Access

    Canadian Association of Gastroenterology Clinical Practice Guideline for the Endoscopic Management of Nonvariceal Nonpeptic Ulcer Upper Gastrointestinal Bleeding

    by Alan N. Barkun, Loren Laine, Grigorios I. Leontiadis, Ian M. Gralnek, Nicholas Carman, Mostafa Ibrahim, Michael Sey, Ali A. Alali, Matthew W. Carroll, Lawrence Hookey, et al.


  • Open Access

    Prioritising Cochrane reviews to be updated with health equity focus

    by Eve Tomlinson, Jordi Pardo Pardo, Torunn Sivesind, Mindy D Szeto, Melissa Laughter, Ruth Foxlee, Michael Brown, Nicole Skoetz, Robert P Dellavalle, Juan Va Franco, et al.

    Background: The prioritisation of updating published systematic reviews of interventions is vital to prevent research waste and ensure relevance to stakeholders. The consideration of health equity in reviews is also important to ensure interventions will not exacerbate the existing inequities of the disadvantaged if universally implemented. This study aimed to pilot a priority setting exercise based on systematic reviews of interventions published in the Cochrane Library, to identify and prioritise reviews to be updated with a focus on health equity.Methods: We conducted a priority setting exercise with a group of 13 international stakeholders. We identified Cochrane reviews of interventions that showed a reduction in mortality, had at least one Summary of Findings table and that focused on one of 42 conditions with a high global burden of disease from the 2019 WHO Global Burden of Disease report. This included 21 conditions used as indicators of success of the United Nations Universal Health Coverage in attaining the Sustainable Development Goals. Stakeholders prioritised reviews that were relevant to disadvantaged populations, or to characteristics of potential disadvantage within the general population.Results: After searching for Cochrane reviews of interventions within 42 conditions, we identified 359 reviews that assessed mortality and included at least one Summary of Findings table. These pertained to 29 of the 42 conditions; 13 priority conditions had no reviews with the outcome mortality. Reducing the list to only reviews showing a clinically important reduction in mortality left 33 reviews. Stakeholders ranked these reviews in order of priority to be updated with a focus on health equity.Conclusions: This project developed and implemented a methodology to set priorities for updating systematic reviews spanning multiple health topics with a health equity focus. It prioritised reviews that reduce overall mortality, are relevant to disadvantaged populations, and focus on conditions with a high global burden of disease. This approach to the prioritisation of systematic reviews of interventions that reduce mortality provides a template that can be extended to reducing morbidity, and the combination of mortality and morbidity as represented in Disability-Adjusted Life Years and Quality-Adjusted Life Years.


  • Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis

    by Frances Tse, Jasmine Liu, Yuhong Yuan, Paul Moayyedi, Grigorios I Leontiadis

    Background Cannulation techniques have been recognized as being important in causing post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). However, considerable controversy exists about the usefulness of the guidewire‐assisted cannulation technique for the prevention of PEP. Objectives To assess the effectiveness and safety of the guidewire‐assisted cannulation technique compared to the conventional contrast‐assisted cannulation technique for the prevention of PEP in people undergoing diagnostic or therapeutic ERCP for biliary or pancreatic diseases. Search methods For the previous version of this review, we searched CENTRAL (the Cochrane Library), MEDLINE, Embase, CINAHL and major conference proceedings, up to February 2012, with no language restrictions. An updated search was performed on 26 February 2021 for the current version of this review. Two clinical trial registries, clinicaltrials.gov and WHO ICTRP, were also searched in this update. Selection criteria Randomized controlled trials (RCTs) comparing the guidewire‐assisted cannulation technique versus the contrast‐assisted cannulation technique in people undergoing ERCP. Data collection and analysis Two review authors conducted study selection, data extraction, and methodological quality assessment independently. Using intention‐to‐treat analysis with random‐effects models, we combined dichotomous data to obtain risk ratios (RR) with 95% confidence intervals (CI). We assessed heterogeneity using the Chi² test (P < 0.10) and I² statistic (> 50%). To explore sources of heterogeneity, we conducted a priori subgroup analyses according to trial design, publication type, risk of bias, use of precut sphincterotomy, inadvertent guidewire insertion or contrast injection of the pancreatic duct (PD), use of a PD stent, cannulation device, and trainee involvement in cannulation. To assess the robustness of our results, we carried out sensitivity analyses using different summary statistics (RR versus odds ratio (OR)) and meta‐analytic models (fixed‐effect versus random‐effects) and per‐protocol analysis. Main results 15 RCTs comprising 4426 participants were included. There was moderate heterogeneity among trials for the outcome of PEP (P = 0.08, I² = 36%). Meta‐analyses suggest that the guidewire‐assisted cannulation technique probably reduces the risk of PEP compared to the contrast‐assisted cannulation technique (RR 0.51, 95% CI 0.36 to 0.72, 15 studies, moderate‐certainty evidence). In addition, the guidewire‐assisted cannulation technique may result in an increase in primary cannulation success (RR 1.06, 95% CI 1.01 to 1.12, 13 studies, low‐certainty evidence), and probably reduces the need for precut sphincterotomy (RR 0.79, 95% CI 0.64 to 0.96, 10 studies, moderate‐certainty evidence). Compared to the contrast‐assisted cannulation technique, the guidewire‐assisted cannulation technique may result in little to no difference in the risk of post‐sphincterotomy bleeding (RR 0.87, 95% CI 0.49 to 1.54, 7 studies, low‐certainty evidence) and perforation (RR 0.93, 95% CI 0.11 to 8.23, 8 studies, very low‐certainty evidence). Procedure‐related mortality was reported by eight studies, and there were no cases of deaths in both arms (moderate‐certainty evidence). Subgroup analyses suggest that the heterogeneity for the outcome of PEP could be explained by differences in trial design. The results were robust in sensitivity analyses. Authors' conclusions There is moderate‐certainty evidence that the guidewire‐assisted cannulation technique probably reduces the risk of PEP compared to the contrast‐assisted cannulation technique. There is low‐certainty evidence that the guidewire‐assisted cannulation technique may result in an increase in primary cannulation success. There is low‐ and very low‐certainty evidence that the guidewire‐assisted cannulation technique may result in little to no difference in the risk of bleeding and perforation. No procedure‐related deaths were reported. Therefore, the guidewire‐assisted cannulation technique appears to be superior to the contrast‐assisted cannulation technique considering the certainty of evidence and the balance of benefits and harms. However, the routine use of guidewires in biliary cannulation will be dependent on local expertise, availability, and cost. Future research should assess the effectiveness and safety of the guidewire‐assisted cannulation technique in the context of other pharmacologic or non‐pharmacologic interventions for the prevention of PEP.


  • Open Access

    COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology

    by Frances Tse, Paul Moayyedi, Kevin A Waschke, Mark MacMillan, Nauzer Forbes, Matthew W Carroll, Nicholas Carman, Grigorios I Leontiadis


  • 1068 - Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: the Canadian Association of Gastroenterology Banff Consensus

    by Desmond Leddin, David A. Lieberman, Grigorios I. Leontiadis, Frances Tse, Alan N. Barkun, Ahmed Abou-Setta, John K. Marshall, N. Jewel Samadder, Harminder Singh, Jennifer J. Telford, et al.

  • Open Access

    Adenocarcinoma Arising from a Gastric Duplication Cyst

    by Brian P.H. Chan, Martin Hyrcza, Jennifer Ramsay, Frances Tse

    Gastric duplication cysts are rare congenital anomalies, and malignant transformation has only been reported in 11 cases. A healthy 57-year-old woman presented with abdominal discomfort, and computed tomography revealed a 5.8 × 6.6 × 8.2 cm mass at the gastric fundus. On endoscopic ultrasound, the mass was mostly hypoechoic with anechoic cystic cavities arising from the submucosal layer. Fine-needle aspiration was suspicious for adenocarcinoma. Surgical pathology confirmed high-grade adenocarcinoma, clear cell cytology arising from a foregut duplication cyst. Endoscopic ultrasound is underutilized in the evaluation duplication cysts and should be considered in routine workup.


  • Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis

    by Frances Tse, Yuhong Yuan, Paul Moayyedi, Grigorios I. Leontiadis, Alan N. Barkun

    Background and study aims Difficult cannulation is a risk factor for pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP). The double-guidewire technique (DGT) may improve cannulation success and reduce the risk of post-ERCP pancreatitis (PEP) in patients with difficult cannulation. This systematic review compared the DGT with persistent conventional cannulation or other advanced techniques in patients with difficult cannulation. Patients and Methods CENTRAL, MEDLINE, EMBASE, and CINAHL databases and DDW and UEGW abstracts up to March 2016 were searched for randomized controlled trials (RCTs) comparing DGT with persistent conventional cannulation or other advanced techniques (precut, pancreatic duct [PD] stenting). The primary outcome was PEP. Secondary outcomes included severity of PEP, successful cannulation of the common bile duct (CBD) with the randomized technique, overall CBD cannulation success, and ERCP-related complications. Results 7 RCTs (577 patients) were included. Use of the DGT significantly increased PEP compared to other endoscopic techniques (risk ratio [RR] 1.98, 95 % confidence interval [95 %CI] 1.14 – 3.42). There was no significant difference in CBD cannulation success with the randomized technique (RR 1.04, 95 %CI 0.87 – 1.24) or in overall cannulation success (RR 1.04, 95 %CI 0.91 – 1.18) between DGT and other techniques. There was also no significant difference in the risk of other ERCP-related complications (bleeding, perforation, cholangitis, and mortality). The results were robust in sensitivity analyses. Conclusions In patients with difficult cannulation, sole use of the DGT appears to increase the risk of PEP without any superiority in achieving biliary cannulation compared to other techniques. PD stenting may reduce the risk of PEP when the DGT is used. The influence of co-intervention in the form of per-procedural nonsteroidal anti-inflammatory drug (NSAID) administration is unclear. * This article is based on a Cochrane Review which has been recently published in the Cochrane Database of Systematic Reviews (CDSR) (Tse et al. Cochrane Database Syst Rev 2016 May 16; (5):CD010571 [1]). Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and the CDSR should be consulted for the most recent version of the review.


  • Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis

    by Frances Tse, Yuhong Yuan, Majidah Bukhari, Grigorios I Leontiadis, Paul Moayyedi, Alan Barkun

    Background Difficult cannulation is a risk factor for post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). It has been postulated that the pancreatic duct guidewire (PGW) technique may improve biliary cannulation success and reduce the risk of PEP in people with difficult cannulation. Objectives To systematically review evidence from randomised controlled trials (RCTs) assessing the effectiveness and safety of the PGW technique compared to persistent conventional cannulation (CC) (contrast‐ or guidewire‐assisted cannulation) or other advanced techniques in people with difficult biliary cannulation for the prevention of PEP. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL databases, major conference proceedings, and for ongoing trials on the ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) up to March 2016, using the Cochrane Upper Gastrointestinal and Pancreatic Diseases model with no language restrictions. Selection criteria RCTs comparing the PGW technique versus persistent CC or other advanced techniques in people undergoing ERCP with difficult biliary cannulation. Data collection and analysis Two review authors independently conducted study selection, data extraction, and methodological quality assessment. Using intention‐to‐treat analysis with random‐effects models, we combined dichotomous data to obtain risk ratios (RR) with 95% confidence intervals (CI). We assessed heterogeneity using the Chi2 test (P < 0.15) and I2 test (> 25%). To explore sources of heterogeneity, we conducted a priori subgroup analyses according to trial design, use of pancreatic duct (PD) stent, involvement of trainees in cannulation, publication type, and risk of bias. To assess the robustness of our results, we carried out sensitivity analyses using different summary statistics (RR versus odds ratio (OR)) and meta‐analytic models (fixed‐effect versus random‐effects). Main results We included seven RCTs comprising 577 participants. There was no significant heterogeneity among trials for the outcome of PEP (P = 0.32; I2 = 15%). The PGW technique significantly increased PEP compared to other endoscopic techniques (RR 1.98, 95% CI 1.14 to 3.42; low‐quality evidence). The number needed to treat for an additional harmful outcome was 13 (95% CI 5 to 89). Among the three studies that compared the PGW technique with persistent CC, the incidence of PEP was 13.5% for the PGW technique and 8.7% for persistent CC (RR 1.58, 95% CI 0.83 to 3.01; low‐quality evidence). Among the two studies that compared the PGW technique with precut sphincterotomy, the incidence of PEP was 29.8% in the PGW group versus 10.3% in the precut group (RR 2.92, 95% CI 1.24 to 6.88; low‐quality evidence). Among the two studies that compared the PGW technique with PD stent placement, the incidence of PEP was 11.7% for the PGW technique and 5.0% for PD stent placement (RR 1.75, 95% CI 0.08 to 37.50; very low‐quality evidence). There was no significant difference in common bile duct (CBD) cannulation success with the randomised technique (RR 1.04, 95% CI 0.87 to 1.24; low‐quality evidence) or overall CBD cannulation success (RR 1.04, 95% CI 0.91 to 1.18; low‐quality evidence) between the PGW technique and other endoscopic techniques. There was also no statistically significant difference in the risk of other ERCP‐related complications (bleeding, perforation, cholangitis, and mortality). The results were robust in sensitivity analyses. The overall quality of evidence for the outcome of PEP was low or very low because of study limitations and imprecision. Authors' conclusions In people with difficult CBD cannulation, sole use of the PGW technique appears to be associated with an increased risk of PEP. Prophylactic PD stenting after use of the PGW technique may reduce the risk of PEP. However, the PGW technique is not superior to persistent attempts with CC, precut sphincterotomy, or PD stent in achieving CBD cannulation. The influence of co‐intervention in the form of rectal peri‐procedural nonsteroidal anti‐inflammatory drug administration is unclear.